Alexander D L, Fisher J F
Upjohn Laboratories, Kalamazoo Michigan 49007-4940, USA.
Steroids. 1995 Mar;60(3):290-4. doi: 10.1016/0039-128x(95)93851-o.
The initial biosynthetic conversions of cholesterol to the bile acids involve sequential 7 alpha-hydroxylation (catalyzed by cholesterol 7 alpha-hydroxylase) followed by C-3 oxidation and concomitant double bond migration (to a delta 4-configuration, catalyzed by 3 beta-delta 5-C27-steroid oxidoreductase) to provide 7 alpha-hydroxycholest-4-en-3-one. A straightforward, and economical, preparation (on a 0.1 g scale) of this pivotal biosynthetic intermediate has been devised. Reduction of 3 beta-(benzoyloxy)-cholest-5-en-7-one with LiB(sec-butyl)3H provided a 4:1 mixture, respectively, of the 7 alpha- and 7 beta-hydroxy diastereomers, which were separated chromatographically. Solvolytic removal of the C-3 benzoyl group gave 3 beta,7 alpha-cholest-5-ene-3,7-diol. A suspension of the 1:1 (v/v) complex (formed by mutual dissolution in MeOH, followed by evaporation of the solvent) of this diol with hydroxypropyl-beta-cyclodextrin, at a concentration of 1 mg mL-1 (in neutral phosphate buffer), was converted by Brevibacterium sp cholesterol oxidase (0.25 U mg-1 of substrate) and catalase (70 U mg-1 of substrate, to recover O2 from the H2O2 produced by the enzymatic oxidation) to a suspension of 7 alpha-hydroxycholest-4-en-3-one and the hydroxypropyl-beta-cyclodextrin. The yield for the enzymatic conversion was in excess of 90%. A much poorer and less reproducible yield (< 20%) was seen in the absence of the hydroxypropyl-beta-cyclodextrin. Routine extraction of this aqueous suspension, and chromatographic purification (85:15 CHCl3/acetone v/v on silica) of the residue, gave pure 7 alpha-hydroxycholest-4-en-3-one in 68% isolated yield. This route is a significant improvement, in terms of reaction scale and convenience, over the previous procedures for the preparation of this steroid.
胆固醇向胆汁酸的初始生物合成转化过程包括依次进行的7α-羟基化反应(由胆固醇7α-羟化酶催化),随后是C-3氧化以及双键的伴随迁移(形成δ4构型,由3β-δ5-C27-类固醇氧化还原酶催化),从而生成7α-羟基胆甾-4-烯-3-酮。现已设计出一种简便且经济的方法(0.1克规模)来制备这种关键的生物合成中间体。用LiB(sec-butyl)3H还原3β-(苯甲酰氧基)-胆甾-5-烯-7-酮,分别得到7α-和7β-羟基非对映异构体的4:1混合物,通过色谱法将其分离。通过溶剂解去除C-3苯甲酰基得到3β,7α-胆甾-5-烯-3,7-二醇。该二醇与羟丙基-β-环糊精以1:1(v/v)形成的复合物(在甲醇中相互溶解,随后蒸发溶剂),以1毫克/毫升的浓度(在中性磷酸盐缓冲液中)悬浮,在短杆菌属胆固醇氧化酶(0.25单位/毫克底物)和过氧化氢酶(70单位/毫克底物,用于从酶促氧化产生的H2O2中回收O2)的作用下,转化为7α-羟基胆甾-4-烯-3-酮和羟丙基-β-环糊精的悬浮液。酶促转化的产率超过90%。在没有羟丙基-β-环糊精的情况下,产率极低且重现性差(<20%)。对该水悬浮液进行常规萃取,并对残留物进行色谱纯化(在硅胶上用85:15 CHCl3/丙酮v/v),得到纯的7α-羟基胆甾-4-烯-3-酮,分离产率为68%。就反应规模和便利性而言,该路线相较于先前制备这种类固醇的方法有显著改进。